Admission to Trading on the OTCQB Venture Market

AI SummaryClose X

OptiBiotix Health plc (AIM: OPTI) announced its shares will begin trading on the OTCQB Venture Market in the United States on August 21, 2025, under the symbol "OPTBF". This will not affect existing shares on the AIM Market of the London Stock Exchange, and no new shares were issued. The company will continue to report through the London Stock Exchange's Regulatory News Service and is not subject to Sarbanes-Oxley or US Securities and Exchange Commission reporting requirements. The company believes this move will increase visibility to US investors, broaden its shareholder base, and improve liquidity.

Disclaimer*

UK 100

Latest directors dealings